Since 2001, approximately 2,400 people using Fosamax have developed Osteonecrosis of the Jaw (ONJ). In 2004, health care professionals urged the FDA to issue a warning about Fosamax and its link to ONJ. In 2010, the FDA issued a warning against Fosamax for frequent femur fractures resulting in a labeling change. Contact the pharmaceutical litigation attorneys at Arias Sanguinetti Wang & Torrijos if you believe you have suffered injuries as a result of taking Fosamax.
Fosamax is a prescription drug used to treat and prevent osteoporosis and other bone diseases in both men and women. It is a bisphosphonate that prevents bone breakdown and increases bone density or thickness for men and for women who have already undergone menopause.
Fosamax has been linked to osteonecrosis of the jaw (ONJ) and rare bone fractures of the femur. Contact a drug litigation attorney if you have taken Fosamax and have experienced any of the following complications:
If you have experienced any of these complications, you may be entitled to compensation for your medical bills, pain, suffering, or other related damages. Our Los Angeles Fosamax bone fracture attorneys at the law offices of Arias Sanguinetti Wang & Torrijos are currently investigating complaints against Fosamax. To discuss your legal options, contact an experienced pharmaceutical attorney today for a free consultation.